123 related articles for article (PubMed ID: 37291851)
1. ABO Blood Group and Bleeding and Survival in VA-ECMO Patients.
Sun GH; Ortoleva JP; Lu SY; Vanneman MW; Tanaka K; Mazzeffi M; Dalia AA
J Intensive Care Med; 2023 Nov; 38(11):1015-1022. PubMed ID: 37291851
[TBL] [Abstract][Full Text] [Related]
2. Red blood cell transfusion requirements for patients on extracorporeal membrane oxygenation.
Choi MH; Alvarez NH; Till BM; Tsypin Y; Sparks B; Hirose H
Perfusion; 2022 May; 37(4):377-384. PubMed ID: 33657914
[TBL] [Abstract][Full Text] [Related]
3. Von Willebrand Factor Concentrate Administration for Acquired Von Willebrand Syndrome- Related Bleeding During Adult Extracorporeal Membrane Oxygenation.
Mazzeffi M; Bathula A; Tabatabai A; Menaker J; Kaczorowski D; Madathil R; Galvagno S; Pasrija C; Rector R; Tanaka K; Herr D
J Cardiothorac Vasc Anesth; 2021 Mar; 35(3):882-887. PubMed ID: 32758410
[TBL] [Abstract][Full Text] [Related]
4. ABO blood group influences transfusion and survival after cardiac surgery.
Welsby IJ; Phillips-Bute B; Mathew JP; Newman MF; Becker R; Rao S; Milano CA; Stafford-Smith M
J Thromb Thrombolysis; 2014 Oct; 38(3):402-8. PubMed ID: 24935230
[TBL] [Abstract][Full Text] [Related]
5. Von Willebrand Factor-GP1bα Interactions in Venoarterial Extracorporeal Membrane Oxygenation Patients.
Mazzeffi M; Hasan S; Abuelkasem E; Meyer M; Deatrick K; Taylor B; Kon Z; Herr D; Tanaka K
J Cardiothorac Vasc Anesth; 2019 Aug; 33(8):2125-2132. PubMed ID: 30595484
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Comparison of Recombinant and Plasma-Derived von Willebrand Factor Concentrate for Treatment of Acquired von Willebrand Syndrome in Adult Extracorporeal Membrane Oxygenation Patients.
Mazzeffi M; Henderson R; Krause E; Rabin J; Madathil R; Chow J; Grazioli A; Meyer M; Wu Z; Tanaka K
Anesth Analg; 2022 Feb; 134(2):312-321. PubMed ID: 34903705
[TBL] [Abstract][Full Text] [Related]
7. ABO blood groups do not predict progression of traumatic intracranial hemorrhage.
Tutunjian AM; Arabian SS; Paolino J; Wolfe ES; Mahoney EJ; Hojman HM; Johnson BP; Bugaev N
J Clin Neurosci; 2021 Aug; 90():345-350. PubMed ID: 34275573
[TBL] [Abstract][Full Text] [Related]
8. Changes in von Willebrand Factor Multimers, Concentration, and Function During Pediatric Extracorporeal Membrane Oxygenation.
Van Den Helm S; Letunica N; Barton R; Weaver A; Yaw HP; Karlaftis V; McCafferty C; Cai T; Newall F; Horton SB; Chiletti R; Johansen A; Best D; McKittrick J; Butt W; d'Udekem Y; MacLaren G; Linden MD; Ignjatovic V; Monagle P
Pediatr Crit Care Med; 2023 Apr; 24(4):268-276. PubMed ID: 36602314
[TBL] [Abstract][Full Text] [Related]
9. Blood Product Utilization in Patients With COVID-19 on ECMO.
George TJ; Sheasby J; Shih E; Lilly JC; Harness-Brumley CL; Taylor JE; Curry MW; Erwin GE; Vaquera KA; Myers DP; DiMaio JM
J Surg Res; 2022 Aug; 276():24-30. PubMed ID: 35334380
[TBL] [Abstract][Full Text] [Related]
10. Safety of recombinant factor VIIa in patients under extracorporeal membrane oxygenation.
Anselmi A; Guinet P; Ruggieri VG; Aymami M; Lelong B; Granry S; Malledant Y; Le Tulzo Y; Gueret P; Verhoye JP; Flecher E
Eur J Cardiothorac Surg; 2016 Jan; 49(1):78-84. PubMed ID: 25908783
[TBL] [Abstract][Full Text] [Related]
11. Acquired von Willebrand syndrome in ECMO patients: A 3-year cohort study.
Panholzer B; Bajorat T; Haneya A; Kowalski D; Juhl D; Rocke A; Shneyder M; Kuta P; Clausnizer H; Junker R; Kowalski A; Tulun A; Al-Suraimi A; Cremer J; Kalbhenn J; Zieger B; Nowak-Göttl U
Blood Cells Mol Dis; 2021 Mar; 87():102526. PubMed ID: 33338698
[TBL] [Abstract][Full Text] [Related]
12. Limb ischemia and bleeding in patients requiring venoarterial extracorporeal membrane oxygenation.
Son AY; Khanh LN; Joung HS; Guerra A; Karim AS; McGregor R; Pawale A; Pham DT; Ho KJ
J Vasc Surg; 2021 Feb; 73(2):593-600. PubMed ID: 32623105
[TBL] [Abstract][Full Text] [Related]
13. Blood and Anticoagulation Management in Extracorporeal Membrane Oxygenation for Surgical and Nonsurgical Patients: A Single-Center Retrospective Review.
Buscher H; Vukomanovic A; Benzimra M; Okada K; Nair P
J Cardiothorac Vasc Anesth; 2017 Jun; 31(3):869-875. PubMed ID: 28082026
[TBL] [Abstract][Full Text] [Related]
14. Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis.
Rios DR; Fernandes AP; Figueiredo RC; Guimarães DA; Ferreira CN; Simões E Silva AC; Carvalho MG; Gomes KB; Dusse LM
J Thromb Thrombolysis; 2012 May; 33(4):416-21. PubMed ID: 22466813
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors of Bleeding in Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation.
Ellouze O; Abbad X; Constandache T; Missaoui A; Berthoud V; Daily T; Aho S; Bouchot O; Bouhemad B; Guinot PG
Ann Thorac Surg; 2021 Feb; 111(2):623-628. PubMed ID: 32171730
[TBL] [Abstract][Full Text] [Related]
16. Different mechanisms of oxygenator failure and high plasma von Willebrand factor antigen influence success and survival of venovenous extracorporeal membrane oxygenation.
Steiger T; Philipp A; Hiller KA; Müller T; Lubnow M; Lehle K
PLoS One; 2021; 16(3):e0248645. PubMed ID: 33735282
[TBL] [Abstract][Full Text] [Related]
17. Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents.
Klarmann D; Eggert C; Geisen C; Becker S; Seifried E; Klingebiel T; Kreuz W
Transfusion; 2010 Jul; 50(7):1571-80. PubMed ID: 20210927
[TBL] [Abstract][Full Text] [Related]
18. Acquired von Willebrand syndrome in patients treated with veno-arterial extracorporeal membrane oxygenation.
Tamura T; Horiuchi H; Obayashi Y; Fuki M; Imanaka M; Kuroda M; Nishimura S; Amano M; Sakamoto J; Tamaki Y; Enomoto S; Miyake M; Kondo H; Izumi C; Nakagawa Y
Cardiovasc Interv Ther; 2019 Oct; 34(4):358-363. PubMed ID: 30656612
[TBL] [Abstract][Full Text] [Related]
19. The effect of ABO blood group on the diagnosis of von Willebrand disease.
Gill JC; Endres-Brooks J; Bauer PJ; Marks WJ; Montgomery RR
Blood; 1987 Jun; 69(6):1691-5. PubMed ID: 3495304
[TBL] [Abstract][Full Text] [Related]
20. ABO identical and washed blood transfusions as candidate strategies to reduce early mortality in acute promyelocytic leukemia.
Sahai T; Henrichs K; Refaai M; Heal JM; Kirkley SA; Schmidt AE; Mendler JH; Masel D; Liesveld J; Aquina C; Blumberg N
Leuk Res; 2017 Nov; 62():1-3. PubMed ID: 28963906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
